AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
MUPIROCINE
7 registrations across 4 African markets— 6 active
Markets with MUPIROCINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BACTROBAN Pommade dermique | 🇹🇳Tunisia | SB HOUSE ENG. | expired | Jul 1990 |
| MONSIN pommade / 2% | 🇸🇳Senegal | RANBAXY LABORATOIRES LIMITED | active | — |
| BACTROBAN pommade nasale / 2 % | 🇸🇳Senegal | SMITH KLINE BEECHAM | active | — |
| ROCIN pommade / 2% | 🇸🇳Senegal | RHYDBURG LLP B9 | active | — |
| DERMOCIN 2.0% P/P POM BTE(1TUB X 15G) LINCOLN Pommade, boîte de 1 tube de | 🇲🇬Madagascar | LINCOLN PHARMACEUTICALS | active | — |
| DERMOCIN 2.0% P/P POM BTE(1TUB X 15G) LINCOLN Pommade, boîte de 1 tube de | 🇲🇬Madagascar | LINCOLN PHARMACEUTICALS | active | — |
| BACTROBAN POMMADE | 🇲🇦Morocco | — | active | — |
MUPIROCINE in Africa — Regulatory Overview
MUPIROCINE is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Madagascar, Morocco, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 6 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.